Jack Nathan Medical Corp. (TSXV:JNH)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jun 6, 2025, 2:44 PM EST
Jack Nathan Medical Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
| -4.91 | 8.71 | 6.89 | 15.49 | 9.64 | 3.85 | |
Revenue Growth (YoY) | - | 26.41% | -55.53% | 60.68% | 150.21% | 6.50% |
Gross Profit | -4.91 | 8.71 | 6.89 | 15.49 | 9.64 | 3.85 |
Selling, General & Admin | -0.63 | 3.46 | 3.65 | 7.66 | 8.62 | 3.89 |
Depreciation & Amortization Expenses | -0.61 | 0.28 | 0.3 | 1.07 | 0.52 | 0.14 |
Research & Development | - | - | - | - | 0.55 | 0.1 |
Other Operating Expenses | -3.52 | 7.45 | 5.24 | 13.71 | 8.43 | 1.07 |
Total Operating Expenses | -4.76 | 11.19 | 9.19 | 22.45 | 18.11 | 5.21 |
Operating Income | 0.26 | -2.48 | -2.31 | -6.96 | -8.47 | -1.35 |
Interest Income | -0 | 0.04 | 0.06 | 0.01 | 0.04 | 0.04 |
Interest Expense | 1.54 | -0.06 | -0.03 | -0.41 | -0.18 | -0.04 |
Other Non-Operating Income (Expense) | 0.27 | -0.01 | 0.14 | 0.37 | 0.38 | -8.94 |
Total Non-Operating Income (Expense) | 1.81 | -0.03 | 0.17 | -0.03 | 0.24 | -8.94 |
Pretax Income | 2.07 | -2.51 | -2.14 | -6.99 | -8.23 | -10.29 |
Provision for Income Taxes | -0.07 | -0.02 | -0.84 | -0.09 | -0.22 | 0.27 |
Net Income | -1.64 | -2.53 | -1.33 | -6.9 | -8.02 | -9.91 |
Minority Interest in Earnings | - | - | - | - | -0.21 | -0.01 |
Earnings From Discontinued Operations | 5.31 | 10 | -5.3 | - | - | - |
Net Income to Common | 3.68 | 7.46 | -6.64 | -6.9 | -7.81 | -9.9 |
Shares Outstanding (Basic) | 87 | 87 | 86 | 84 | 82 | 52 |
Shares Outstanding (Diluted) | 83 | 87 | 94 | 84 | 82 | 52 |
Shares Change (YoY) | -14.19% | -6.52% | 10.96% | 2.52% | 59.28% | 16.28% |
EPS (Basic) | 0.03 | -0.03 | -0.02 | -0.08 | -0.10 | -0.19 |
EPS (Diluted) | 0.03 | -0.03 | -0.01 | -0.08 | -0.10 | -0.19 |
EPS Growth | 200.00% | - | - | - | - | - |
Free Cash Flow | -1.83 | -6.92 | -10.2 | -4.59 | -5.29 | -1.31 |
Free Cash Flow Per Share | -0.02 | -0.08 | -0.11 | -0.05 | -0.06 | -0.03 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -5.27% | -28.48% | -33.47% | -44.94% | -87.86% | -35.16% |
Profit Margin | 33.30% | -29.06% | -19.36% | -44.57% | -83.16% | -257.34% |
FCF Margin | 37.19% | -79.45% | -148.05% | -29.64% | -54.90% | -33.98% |
EBITDA | 0.49 | -1.38 | -1.13 | -5.89 | -7.95 | -1.21 |
EBITDA Margin | -9.95% | -15.82% | -16.35% | -38.03% | -82.50% | -31.40% |
EBIT | 0.26 | -2.48 | -2.31 | -6.96 | -8.47 | -1.35 |
EBIT Margin | -5.27% | -28.48% | -33.47% | -44.94% | -87.86% | -35.16% |
Effective Tax Rate | -3.26% | 0.65% | 39.49% | 1.23% | 2.64% | -2.60% |